Karolinska Institutet

Northwell, drug-maker ink bioelectronics partnership

By GREGORY ZELLER // Bioelectronic medicine has taken another forward leap, thanks to the Feinstein Institute for Medical Research’s latest professional alliance. The research-and-development arm of the Northwell Health system announced Thursday that it will apply its cutting-edge bioelectronics and cell-therapy technologies to cardiology and hypertension cases through a new “strategic partnership” with United Therapeutics Corp. Financial terms were not disclosed, but United Therapeutics will “fund Northwell’s efforts in four research-and-development tracks” while ushering new…


Feinstein eyes bioelectronic BP breakthrough

A new study by the head of the Feinstein Institute for Medical Research may open the door to bioelectronic treatments for hypertension and high blood pressure. In a study published this month by the prestigious peer-reviewed scientific journal Nature Biotechnology, researchers from the Feinstein Institute – the R&D arm of the Northwell Health system – and the Karolinska Institutet, Sweden’s top medical university, discuss findings regarding T-cells and their ability to produce neurotransmitters that can…


Feinstein’s Tracey to head bioelectronics summit

Feinstein Institute chief and global bioelectronics pioneer Kevin Tracey will headline a September New York Academy of Science conference on bioelectronic medicine. Tracey, Feinstein’s president and CEO and the brains behind bioelectronic startup Sanguistat, will share keynote duties with Peder Olofsson, a longtime Feinstein Institute researcher and Wallenberg Academy Fellow at the Karolinska Institutet. The two will headline Key Symposium 2016: Bioelectronic Medicine – Technology Targeting Molecular Mechanisms, presented by the Feinstein Institute, the Royal…